M2Gen Board of Directors
M2Gen® is a health informatics solutions company focused on accelerating the discovery and development of personalized medicines. M2Gen partners with the nation’s leading cancer centers through ORIEN to create a large, cancer-focused data warehouse linking clinical and molecular data. Using this information, M2Gen helps biopharmaceutical companies address the greatest challenges in oncology drug development.
Mr. Theodore J. Couch Sr., Chair
Senator Connie Mack, Vice Chair
Liberty Partners Group
William S. Dalton, Ph.D., M.D.
CEO, M2Gen; Director, Personalized Medicine Institute, Moffitt Cancer Center
Kenneth Ford, Ph.D.
Founder & CEO, Florida Institute for Human & Machine Cognition
Jack A. Kolosky
Executive Vice President & COO; President, Moffitt Hospital
Mr. Allan S. Martin
Founder & Chairman, Atlantic Merchant Capital Investors, LLC
Mr. Kenneth I. Moch
The Honorable H. Lee Moffitt
Former Speaker, Florida House of Representatives; Founder, Moffitt Cancer Center
Ms. Linda Powers
Toucan Capital Fund
Mr. Robert Rothman
President & CEO, Black Diamond Group
Mr. Timothy R. Wright
Executive Vice President of Strategy and Global Business Development, Teva Pharmaceuticals